2. Gene
  3. Dpp4 - dipeptidylpeptidase 4 Gene

Dpp4 - dipeptidylpeptidase 4 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：二肽基肽酶4

种属: Rattus norvegicus

同用名: CD26; DPPIV

基因 ID: 25253 | 基因类型: protein coding

关于 Dpp4

Primary_assembly 3: 46,962,243-47,043,901 reverse strand.mRatBN7.2:CM026976.1

This gene has 3 transcripts (splice variants), 209 orthologues, 6 paralogues and is associated with 36 phenotypes. Biased expression in Kidney (RPKM 1492.6), Liver (RPKM 372.) and 3 other tissues.

功能概要

该基因编码的蛋白可启动多种功能，包括胶原蛋白结合活性；二肽基肽酶活性；和相同的蛋白质结合活性。参与多个过程，包括 B-1a B 细胞分化；蛋白水解；和调节淋巴细胞介导的免疫。位于多种细胞成分中，包括高尔基体；细胞表面；和内质网。该基因的人类直系同源物与中东呼吸综合征和 2 型糖尿病有关。与人 DPP4（二肽基肽酶 4）同源。 [由基因组资源联盟提供，2022 年 4 月]

Enables several functions, including collagen binding activity; dipeptidyl-peptidase activity; and identical protein binding activity. Involved in several processes, including B-1a B cell differentiation; proteolysis; and regulation of lymphocyte mediated immunity. Located in several cellular components, including Golgi apparatus; cell surface; and endoplasmic reticulum. Human ortholog(s) of this gene implicated in Middle East respiratory syndrome and type 2 diabetes mellitus. Orthologous to human DPP4 (Dipeptidyl Peptidase 4). [provided by Alliance of Genome Resources, Apr 2022]

Dpp4 基因产物(1)

mRNA Protein Name
NM_012789.2 NP_036921.2 dipeptidyl peptidase 4
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables collagen binding IDA
IDA: 通过直接分析推断
8526932 RGD
enables dipeptidyl-peptidase activity IDA
IDA: 通过直接分析推断
10931192 RGD
enables dipeptidyl-peptidase activity IMP
IMP: 通过突变表型推断
9210490 RGD
enables identical protein binding IMP
IMP: 通过突变表型推断
9210490 RGD
enables identical protein binding IPI
IPI: 通过物理相互作用推断
10931192 RGD
enables peptide binding IDA
IDA: 通过直接分析推断
17415460 RGD
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in B-1a B cell differentiation IMP
IMP: 通过突变表型推断
19327106 RGD
involved in positive regulation of natural killer cell mediated immunity IMP
IMP: 通过突变表型推断
19327106 RGD
involved in protein catabolic process IDA
IDA: 通过直接分析推断
17415460 RGD
involved in regulation of T cell mediated immunity IMP
IMP: 通过突变表型推断
15606609 RGD
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in cell surface IDA
IDA: 通过直接分析推断
10931192 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

Dpp4 蛋白结构

DPPIV_rep

DPPIV_rep: pfam18811 (35 - 55)

DPPIV_N

DPPIV_N: pfam00930 (105 - 478)

Peptidase_S9

Peptidase_S9: pfam00326 (559 - 763)

  • 0
  • 200
  • 400
  • 600
  • 767 a.a.
蛋白主名 其他名称

dipeptidyl peptidase 4

DPP IV

GP110 glycoprotein

T-cell activation antigen CD26

bile canaliculus domain-specific membrane glycoprotein

dipeptidyl peptidase IV

相关产品

Approval
生物活性分子 (20)
目录号 产品名 作用方式
纯度 是否罕见病
HY-13749 Sitagliptin Inhibitor 99.75% 是
HY-10284 Linagliptin 99.91% 否
HY-13749A Sitagliptin phosphate Inhibitor 99.85% 是
HY-15981 Omarigliptin Inhibitor / 否
HY-10285 Saxagliptin Inhibitor 99.96% 是
HY-13749B Sitagliptin phosphate monohydrate Inhibitor 99.49% 是
HY-14806 Teneligliptin Inhibitor 99.85% 否
HY-A0023 Alogliptin Benzoate Inhibitor 99.99% 否
HY-A0023A Alogliptin Inhibitor 99.92% 否
HY-15408 Trelagliptin Inhibitor 99.54% 否
HY-14806B Teneligliptin hydrobromide hydrate Inhibitor 99.87% 否
HY-14877 Anagliptin Inhibitor 99.91% 否
HY-15408A Trelagliptin succinate Inhibitor 99.96% 否
HY-14806A Teneligliptin hydrobromide Inhibitor 99.99% 否
HY-16448 Saxagliptin hydrochloride Inhibitor 99.71% 是
HY-14892 Gemigliptin Inhibitor / 否
HY-108795A Albiglutide fragment TFA Agonist 99.12% 否
HY-10285A Saxagliptin hydrate Inhibitor ≥99.0% 是
HY-14877A Anagliptin hydrochloride Inhibitor / 否
HY-108795 Albiglutide fragment Agonist / 否
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9805 Anti-MERS-3A1 mAb Inhibitor / 否
HY-P9806 Anti-MERS-D12 mAb Inhibitor / 否
Clinical Phase
生物活性分子 (8)
目录号 产品名 作用方式
纯度 Phase
HY-117985B Evogliptin tartrate 99.71% Phase 4
HY-14806S Teneligliptin-d8 Inhibitor / Phase 4
HY-117985 Evogliptin / Phase 4
HY-10286 Dutogliptin Inhibitor 99.32% Phase 3
HY-112668 Retagliptin phosphate Inhibitor 99.89% Phase 3
HY-147257 Cofrogliptin Inhibitor 99.07% Phase 3
HY-10286A Dutogliptin tartrate Inhibitor / Phase 3
HY-12528 DBPR108 Inhibitor 98.75% Phase 1
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P99466 Begelomab Inhibitor ≥95.0% Phase 3
Pre-clinical Phase
生物活性分子 (58)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P1141 GLP-1(9-36)amide Antagonist 99.78% 否
HY-14892A Gemigliptin tartrate Inhibitor 98.17% 否
HY-P2543 Neuropeptide Y (3-36) (human, rat) Agonist 95.78% 否
HY-112668A Retagliptin Inhibitor 98.51% 否
HY-N6079 Timosaponin A1 Inhibitor 99.24% 否
HY-P1141A GLP-1(9-36)amide TFA Antagonist 98.00% 否
HY-147401 Sitagliptin fenilalanil Inhibitor 99.76% 否
HY-13749AS Sitagliptin-d4 phosphate Inhibitor 99.48% 否
HY-123377A Fotagliptin benzoate Inhibitor 99.19% 否
HY-A0023AS1 Alogliptin-d3 Inhibitor 99.61% 否
HY-10284S Linagliptin-d4 99.62% 否
HY-124958 NDMC101 Inhibitor 99.91% 否
HY-13749S1 Sitagliptin-d4 hydrochloride / 否
HY-A0023AS Alogliptin-13C,d3 Inhibitor / 否
HY-RS03963 DPP4 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-112668B Retagliptin hydrochloride / 否
HY-117985A Evogliptin hydrochloride Inhibitor / 否
HY-123377 Fotagliptin Inhibitor / 否
HY-147401A Sitagliptin fenilalanil hydrochloride Inhibitor 98.94% 否
HY-10284S1 Linagliptin-13C,d3 / 否
HY-10284S3 Linagliptin-d3-1 / 否
HY-120828 Albenatide Agonist / 否
HY-121029 Bisegliptin / 否
HY-125330 Denagliptin tosylate / 否
HY-129736 P32/98 hemifumarate Inhibitor / 否
HY-129736A P32/98 Inhibitor / 否
HY-13749C (S)-Sitagliptin phosphate Inhibitor / 否
HY-146455 DPP-4-IN-3 Inhibitor / 否
HY-146468 DPP-4/GPR119 modulator 1 / 否
HY-146469 DPP-4/GPR119 modulator 2 / 否
HY-14806S1 Teneligliptin-d4 Inhibitor / 否
HY-151383 DPP-4-IN-1 Inhibitor / 否
HY-151384 DPP-4-IN-2 Inhibitor / 否
HY-15408S Trelagliptin-13C,d3 Inhibitor / 否
HY-155027 DPP-4-IN-8 Inhibitor / 否
HY-155961 Antidiabetic agent 2 Inhibitor / 否
HY-157390 DPP-4-IN-9 Inhibitor / 否
HY-158315 NZ-97 Inhibitor / 否
HY-159491 DPP-4-IN-11 Inhibitor / 否
HY-161428 ZINC000003015356 Inhibitor / 否
HY-162513 DPP-4-IN-10 Inhibitor / 否
HY-163332 MPO-IN-6 Inhibitor / 否
HY-168621 DPP-4-IN-13 Inhibitor / 否
HY-169110 DPP-4-IN-12 Inhibitor / 否
HY-N9725 16-Hydroxycleroda-3,13-dien-15,16-olide Inhibitor / 否
HY-P6177 SGP8 Inhibitor / 否
HY-RS03964 Dpp4 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS03965 Dpp4 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-103432 DPP4-In / 否
HY-109060 Garvagliptin Inhibitor / 否
HY-110051 DPP4-In hydrochloride / 否
HY-119266 HTS13517 Inhibitor / 否
HY-13749D (Rac)-Sitagliptin Inhibitor / 否
HY-139792 Besigliptin tosylate / 否
HY-16656 BMS-767778 Inhibitor / 否
HY-167680 Denagliptin / 否
HY-N8134 2-Methoxy-5-acetoxy-fruranogermacr-1(10)-en-6-one Inhibitor / 否
HY-W003592A L-Orinithine lactam hydrochloride / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Dpp4 NCBI NCBI:1803
Macaca fascicularis Dpp4 NCBI NCBI:102133935
Mus musculus Dpp4 NCBI NCBI:13482
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z